Search / Trial NCT06223217

Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.

Launched by RENJI HOSPITAL · Jan 16, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

In the prior study, the original 25-item VascuQol Scale demonstrates the limitation of dimensional mixing. As a result, we suggest improving the original scale by integrating the five dimensions and simplifying the objects. 480 patients will be recruited to complete the Chinese version of VascuQol Scale and the modified version. Reliability, validity, responsiveness, and diagnostic accuracy for CLTI will be used to evaluate whether the modified scale could serve as an effective biopsychosocial assessment tool for patients suffering from lower extremity peripheral arterial disease. Study Pr...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female aged 18-90
  • 2. The patient is diagnosed with lower extremity peripheral arterial disease
  • 3. The patient is willing to comply with specified follow-up evaluations at the specified times
  • 4. The patient understands the nature of the procedure and provides written informed consent before enrolment in the study
  • 5. Before enrolment, the guidewire has crossed the target lesion
  • 6. No restrictions on Rutherford grading, TASC grading, GLASS grading
  • Exclusion Criteria:
  • 1. Pregnant women or Female patients with potential childbearing
  • 2. The patient is currently participating in another investigational drug or device study that has not reached the primary endpoint.
  • 3. Patients unwilling or refusing to sign informed consent
  • 4. Patients with other diseases that may seriously affect the quality of life, such as tumors, severe liver disease, cardiac insufficiency, etc., or those with a life expectancy of less than 2 years

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Shanghai, Shanghai, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0